Docking and Selectivity Studies of Covalently Bound Janus Kinase 3 Inhibitors
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24076023 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Haizhen A Zhong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The University of Nebraska at Omaha, 6001 Dodge Street, Omaha, NE 68182, USA. Hauptthemen laut MEDLINE: Janus Kinase 3, Protein Kinase Inhibitors. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Nebraska at Omaha, Qassim University, Saudi Arabia, the University of Nebraska, Omaha.
Abstract (Originalsprache)
The Janus kinases (JAKs) are a family of non-receptor cytosolic protein kinases critical for immune signaling. Many covalently bound ligands of JAK3 inhibitors have been reported. To help design selective JAK inhibitors, in this paper, we used five model proteins to study the subtype selectivity of and the mutational effects on inhibitor binding. We also compared the Covalent Dock programs from the Schrodinger software suite and the MOE software suite to determine which method to use for the drug design of covalent inhibitors. Our results showed that the docking affinity from 4Z16 (JAK3 wild-type model), 4E4N (JAK1), 4D1S (JAK2), and 7UYT (TYK2) from the Schrödinger software suite agreed well with the experimentally derived binding free energies with small predicted mean errors. However, the data from the mutant 5TTV model using the Schrödinger software suite yielded relatively large mean errors, whereas the MOE Covalent Dock program gave small mean errors in both the wild-type and mutant models for our model proteins. The docking data revealed that Leu905 of JAK3 and the hydrophobic residue at the same position in different subtypes (Leu959 of JAK1, Leu932 of JAK2, and Val981 of TYK2) is important for ligand binding to the JAK proteins. Arg911 and Asp912 of JAK3, Asp939 of JAK2, and Asp988 of TYK2 can be used for selective binding over JAK1, which contains Lys965 and Glu966 at the respective positions. Asp1021, Asp1039, and Asp1042 can be utilized for JAK1-selective ligand design, whereas Arg901 and Val981 may help guide TYK2-selective molecule design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, The University of Nebraska at Omaha, 6001 Dodge Street, Omaha, NE 68182, USA.
- Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraidah 51542, Saudi Arabia.
ORCID-Profile: Haizhen A Zhong
Förderung
- University of Nebraska at Omaha
- Qassim University, Saudi Arabia
- the University of Nebraska, Omaha
- the Ministry of Education Scholarship, Qassim University
Zitieren
APA
Zhong, H. A., & Almahmoud, S. (2023). Docking and Selectivity Studies of Covalently Bound Janus Kinase 3 Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076023
Vancouver
Zhong HA, Almahmoud S. Docking and Selectivity Studies of Covalently Bound Janus Kinase 3 Inhibitors. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076023
BibTeX
@article{Zhong2023,
author = {Zhong, Haizhen A and Almahmoud, Suliman},
title = {Docking and Selectivity Studies of Covalently Bound Janus Kinase 3 Inhibitors},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076023}
}
EUVIMED